These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
323 related articles for article (PubMed ID: 25442815)
1. CA 19-9 as a marker in addition to CEA to monitor colorectal cancer. Stiksma J; Grootendorst DC; van der Linden PW Clin Colorectal Cancer; 2014 Dec; 13(4):239-44. PubMed ID: 25442815 [TBL] [Abstract][Full Text] [Related]
2. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer. Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694 [TBL] [Abstract][Full Text] [Related]
3. Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer? Chen CC; Yang SH; Lin JK; Lin TC; Chen WS; Jiang JK; Wang HS; Chang SC J Surg Res; 2005 Apr; 124(2):169-74. PubMed ID: 15820244 [TBL] [Abstract][Full Text] [Related]
4. A comparison of tumour M2-PK with carcinoembryonic antigen and CA19-9 in patients undergoing liver resection for colorectal metastases. Kumar Y; Pinedo IR; Tapuria N; Zabron A; Davidson BR Eur J Gastroenterol Hepatol; 2008 Oct; 20(10):1006-11. PubMed ID: 18787469 [TBL] [Abstract][Full Text] [Related]
5. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer. Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401 [TBL] [Abstract][Full Text] [Related]
6. Serological studies on CEA, CA 19-9, STn and SLX in colorectal cancer. Sato T; Nishimura G; Nonomura A; Miwa K; Miyazaki I Hepatogastroenterology; 1999; 46(26):914-9. PubMed ID: 10370638 [TBL] [Abstract][Full Text] [Related]
7. [Prognostic study of preoperative serum levels of CEA and CA 19-9 in colorectal cancer]. Uehara M; Manaka D; Baba S; Oji Y; Hirata K; Shimizu M; Noguchi M Gan To Kagaku Ryoho; 2007 Sep; 34(9):1413-7. PubMed ID: 17876139 [TBL] [Abstract][Full Text] [Related]
8. [Arginase as a marker of cancerogenesis. III. Comparison of arginase activity with CEA and Ca 19-9 in liver metastases of colorectal cancer]. Porembska Z; Skwarek A; Chrzanowska A; Mielczarek M; Nyckowski P; Barańczyk-Kuźma A Pol Merkur Lekarski; 2004 Jan; 16(91):31-3. PubMed ID: 15074017 [TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of predictive biomarkers for therapeutical strategies in colorectal cancer. Gasser M; Gerstlauer C; Grimm M; Bueter M; Lebedeva T; Lutz J; Maeder U; Ribas C; Ribas C; Nichiporuk E; Thalheimer A; Heemann U; Thiede A; Meyer D; Waaga-Gasser AM Ann Surg Oncol; 2007 Apr; 14(4):1272-84. PubMed ID: 17211733 [TBL] [Abstract][Full Text] [Related]
10. [The pre- and postoperative monitoring of the immunological indices and tumor markers in colorectal carcinoma]. Iarŭmov N; Ignatov A; Viiachki I Khirurgiia (Sofiia); 1998; 51(3):42-8. PubMed ID: 9974027 [TBL] [Abstract][Full Text] [Related]
11. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer. Griesenberg D; Nürnberg R; Bahlo M; Klapdor R Anticancer Res; 1999; 19(4A):2443-50. PubMed ID: 10470173 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value of preoperative CEA and CA 19-9 levels in patients with colorectal cancer. Basbug M; Arikanoglu Z; Bulbuller N; Cetinkaya Z; Aygen E; Akbulut S; Satici O Hepatogastroenterology; 2011; 58(106):400-5. PubMed ID: 21661403 [TBL] [Abstract][Full Text] [Related]
13. Significance of CEA and CA19-9 combination as a prognostic indicator and for recurrence monitoring in patients with stage II colorectal cancer. Shibutani M; Maeda K; Nagahara H; Ohtani H; Sakurai K; Toyokawa T; Kubo N; Tanaka H; Muguruma K; Ohira M; Hirakawa K Anticancer Res; 2014 Jul; 34(7):3753-8. PubMed ID: 24982398 [TBL] [Abstract][Full Text] [Related]
14. [Antigens (CEA and CA 19-9) in diagnosis and prognosis colorectal cancer]. Grotowski M Pol Merkur Lekarski; 2002 Jan; 12(67):77-80. PubMed ID: 11957811 [TBL] [Abstract][Full Text] [Related]
15. CEA and CA 19-9 as prognostic indexes in colorectal cancer. Forones NM; Tanaka M Hepatogastroenterology; 1999; 46(26):905-8. PubMed ID: 10370636 [TBL] [Abstract][Full Text] [Related]
16. Clinical significance of CEA and CA19-9 in postoperative follow-up of colorectal cancer. Yakabe T; Nakafusa Y; Sumi K; Miyoshi A; Kitajima Y; Sato S; Noshiro H; Miyazaki K Ann Surg Oncol; 2010 Sep; 17(9):2349-56. PubMed ID: 20217258 [TBL] [Abstract][Full Text] [Related]
17. Preoperative serum levels of CEA and CA 19-9 and their prognostic significance in colorectal carcinoma. Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Pahl H; Fateh-Moghadam A Anticancer Res; 1997; 17(4B):2935-8. PubMed ID: 9329568 [TBL] [Abstract][Full Text] [Related]
18. Tumor markers in staging and prognosis of colorectal carcinoma. Levy M; Visokai V; Lipska L; Topolcan O Neoplasma; 2008; 55(2):138-42. PubMed ID: 18237252 [TBL] [Abstract][Full Text] [Related]
19. Tumor markers in patients with relapse of colorectal carcinoma. Lipská L; Visokai V; Levý M; Svobodová S; Kormunda S; Fínek J Anticancer Res; 2007; 27(4A):1901-5. PubMed ID: 17649792 [TBL] [Abstract][Full Text] [Related]
20. Usefulness of CEA, TPA, GICA, CA 72.4, and CA 195 in the Diagnosis of primary colorectal cancer and at its relapse. Nicolini A; Caciagli M; Zampieri F; Ciampalini G; Carpi A; Spisni R; Colizzi C Cancer Detect Prev; 1995; 19(2):183-95. PubMed ID: 7750106 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]